Go Pro

CareCloud (CCLD) Competitors

CareCloud logo
$2.51 -0.12 (-4.56%)
As of 08/21/2026 04:00 PM Eastern

CCLD vs. WEAV, TBRG, AMWL, HCAT, and OPRX

Should you buy CareCloud stock or one of its competitors? CareCloud's main competitors and comparable companies include Weave Communications (WEAV), TruBridge (TBRG), American Well (AMWL), Health Catalyst (HCAT), and OptimizeRx (OPRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does CareCloud compare to Weave Communications?

CareCloud (NASDAQ:CCLD) and Weave Communications (NYSE:WEAV) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 86.8% of Weave Communications shares are owned by institutional investors. 14.8% of CareCloud shares are owned by company insiders. Comparatively, 16.4% of Weave Communications shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

CareCloud has a beta of 1.51, suggesting that its stock price is 51% more volatile than the broader market. Comparatively, Weave Communications has a beta of 1.67, suggesting that its stock price is 67% more volatile than the broader market.

CareCloud has a net margin of 6.21% compared to Weave Communications' net margin of -7.97%. CareCloud's return on equity of 27.07% beat Weave Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
CareCloud6.21% 27.07% 14.56%
Weave Communications -7.97%-21.14%-8.41%

In the previous week, Weave Communications had 22 more articles in the media than CareCloud. MarketBeat recorded 25 mentions for Weave Communications and 3 mentions for CareCloud. CareCloud's average media sentiment score of 0.33 beat Weave Communications' score of 0.17 indicating that CareCloud is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CareCloud
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Weave Communications
5 Very Positive mention(s)
4 Positive mention(s)
11 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

CareCloud currently has a consensus target price of $3.25, suggesting a potential upside of 29.48%. Weave Communications has a consensus target price of $7.84, suggesting a potential upside of 7.40%. Given CareCloud's stronger consensus rating and higher probable upside, research analysts plainly believe CareCloud is more favorable than Weave Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareCloud
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Weave Communications
1 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25

CareCloud has higher earnings, but lower revenue than Weave Communications. Weave Communications is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareCloud$128.64M0.83$10.80M$0.0735.86
Weave Communications$239.02M2.44-$28.05M-$0.25N/A

Summary

CareCloud beats Weave Communications on 9 of the 16 factors compared between the two stocks.

How does CareCloud compare to TruBridge?

CareCloud (NASDAQ:CCLD) and TruBridge (NASDAQ:TBRG) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

CareCloud presently has a consensus price target of $3.25, suggesting a potential upside of 29.48%. TruBridge has a consensus price target of $23.95, suggesting a potential downside of 8.73%. Given CareCloud's stronger consensus rating and higher possible upside, analysts plainly believe CareCloud is more favorable than TruBridge.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareCloud
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
TruBridge
0 Sell rating(s)
8 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

CareCloud has a beta of 1.51, meaning that its share price is 51% more volatile than the broader market. Comparatively, TruBridge has a beta of 1.28, meaning that its share price is 28% more volatile than the broader market.

CareCloud has a net margin of 6.21% compared to TruBridge's net margin of 0.92%. CareCloud's return on equity of 27.07% beat TruBridge's return on equity.

Company Net Margins Return on Equity Return on Assets
CareCloud6.21% 27.07% 14.56%
TruBridge 0.92%18.75%8.32%

In the previous week, TruBridge had 1 more articles in the media than CareCloud. MarketBeat recorded 4 mentions for TruBridge and 3 mentions for CareCloud. CareCloud's average media sentiment score of 0.33 beat TruBridge's score of 0.00 indicating that CareCloud is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CareCloud
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
TruBridge
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CareCloud has higher earnings, but lower revenue than TruBridge. CareCloud is trading at a lower price-to-earnings ratio than TruBridge, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareCloud$128.64M0.83$10.80M$0.0735.86
TruBridge$346.84M1.13$4.21M$0.20131.20

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 88.6% of TruBridge shares are owned by institutional investors. 14.8% of CareCloud shares are owned by insiders. Comparatively, 10.7% of TruBridge shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

CareCloud beats TruBridge on 10 of the 16 factors compared between the two stocks.

How does CareCloud compare to American Well?

American Well (NYSE:AMWL) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, media sentiment, valuation and dividends.

CareCloud has a net margin of 6.21% compared to American Well's net margin of -35.75%. CareCloud's return on equity of 27.07% beat American Well's return on equity.

Company Net Margins Return on Equity Return on Assets
American Well-35.75% -30.12% -22.30%
CareCloud 6.21%27.07%14.56%

In the previous week, CareCloud had 1 more articles in the media than American Well. MarketBeat recorded 3 mentions for CareCloud and 2 mentions for American Well. American Well's average media sentiment score of 1.24 beat CareCloud's score of 0.33 indicating that American Well is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
American Well
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CareCloud
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

CareCloud has lower revenue, but higher earnings than American Well. American Well is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Well$249.32M0.79-$95.70M-$4.77N/A
CareCloud$128.64M0.83$10.80M$0.0735.86

American Well has a beta of 1.68, indicating that its stock price is 68% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.51, indicating that its stock price is 51% more volatile than the broader market.

56.1% of American Well shares are owned by institutional investors. Comparatively, 10.2% of CareCloud shares are owned by institutional investors. 12.8% of American Well shares are owned by insiders. Comparatively, 14.8% of CareCloud shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

American Well presently has a consensus target price of $9.50, indicating a potential downside of 19.76%. CareCloud has a consensus target price of $3.25, indicating a potential upside of 29.48%. Given CareCloud's stronger consensus rating and higher probable upside, analysts plainly believe CareCloud is more favorable than American Well.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
American Well
1 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
CareCloud
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

CareCloud beats American Well on 11 of the 15 factors compared between the two stocks.

How does CareCloud compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends.

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 10.2% of CareCloud shares are held by institutional investors. 19.4% of Health Catalyst shares are held by company insiders. Comparatively, 14.8% of CareCloud shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Health Catalyst has a beta of 1.55, suggesting that its share price is 55% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.51, suggesting that its share price is 51% more volatile than the broader market.

CareCloud has a net margin of 6.21% compared to Health Catalyst's net margin of -90.61%. CareCloud's return on equity of 27.07% beat Health Catalyst's return on equity.

Company Net Margins Return on Equity Return on Assets
Health Catalyst-90.61% -1.83% -0.80%
CareCloud 6.21%27.07%14.56%

Health Catalyst presently has a consensus price target of $2.82, suggesting a potential upside of 84.49%. CareCloud has a consensus price target of $3.25, suggesting a potential upside of 29.48%. Given Health Catalyst's higher probable upside, equities research analysts clearly believe Health Catalyst is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Catalyst
1 Sell rating(s)
9 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.15
CareCloud
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

In the previous week, CareCloud had 2 more articles in the media than Health Catalyst. MarketBeat recorded 3 mentions for CareCloud and 1 mentions for Health Catalyst. CareCloud's average media sentiment score of 0.33 beat Health Catalyst's score of 0.12 indicating that CareCloud is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health Catalyst
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CareCloud
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

CareCloud has lower revenue, but higher earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health Catalyst$311.14M0.37-$177.97M-$3.68N/A
CareCloud$128.64M0.83$10.80M$0.0735.86

Summary

CareCloud beats Health Catalyst on 10 of the 16 factors compared between the two stocks.

How does CareCloud compare to OptimizeRx?

OptimizeRx (NASDAQ:OPRX) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, risk, analyst recommendations and valuation.

OptimizeRx currently has a consensus target price of $11.43, suggesting a potential upside of 48.23%. CareCloud has a consensus target price of $3.25, suggesting a potential upside of 29.48%. Given OptimizeRx's stronger consensus rating and higher possible upside, equities research analysts clearly believe OptimizeRx is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OptimizeRx
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56
CareCloud
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

76.5% of OptimizeRx shares are held by institutional investors. Comparatively, 10.2% of CareCloud shares are held by institutional investors. 7.5% of OptimizeRx shares are held by insiders. Comparatively, 14.8% of CareCloud shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

CareCloud has higher revenue and earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OptimizeRx$109.43M1.33$5.13M$0.2333.52
CareCloud$128.64M0.83$10.80M$0.0735.86

CareCloud has a net margin of 6.21% compared to OptimizeRx's net margin of 4.66%. CareCloud's return on equity of 27.07% beat OptimizeRx's return on equity.

Company Net Margins Return on Equity Return on Assets
OptimizeRx4.66% 9.44% 7.11%
CareCloud 6.21%27.07%14.56%

In the previous week, CareCloud had 1 more articles in the media than OptimizeRx. MarketBeat recorded 3 mentions for CareCloud and 2 mentions for OptimizeRx. CareCloud's average media sentiment score of 0.33 beat OptimizeRx's score of 0.00 indicating that CareCloud is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OptimizeRx
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CareCloud
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

OptimizeRx has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.51, meaning that its stock price is 51% more volatile than the broader market.

Summary

CareCloud beats OptimizeRx on 10 of the 16 factors compared between the two stocks.

Get CareCloud News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCLD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCLD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCLD vs. The Competition

MetricCareCloudHealthcare Technology IndustryHealthcare SectorNASDAQ Exchange
Market Cap$111.76M$1.72B$7.26B$12.77B
Dividend YieldN/A4.70%2.54%11.08%
P/E Ratio35.8621.43273.1824.24
Price / Sales0.8375.74689.05129.21
Price / Cash3.8231.7476.8953.23
Price / Book6.126.9813.456.38
Net Income$10.80M-$18.66M$3.47B$348.73M
7 Day Performance-3.09%0.54%2.08%0.08%
1 Month Performance14.61%11.11%6.10%2.91%
1 Year Performance-11.31%-17.07%24.99%17.19%

CareCloud Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CCLD
CareCloud
3.8474 of 5 stars
$2.51
-4.6%
$3.25
+29.5%
-7.7%$111.76M$128.64M35.863,650
WEAV
Weave Communications
1.8489 of 5 stars
$5.02
-5.9%
$8.33
+66.2%
-4.5%$399.04M$239.02MN/A890
TBRG
TruBridge
0.315 of 5 stars
$26.24
flat
$23.95
-8.7%
N/A$393.60M$346.84M131.203,500
AMWL
American Well
2.7961 of 5 stars
$13.02
-4.1%
$8.60
-33.9%
+69.7%$215.48M$249.32MN/A1,040
HCAT
Health Catalyst
2.6983 of 5 stars
$1.76
+2.3%
$2.95
+67.9%
-50.0%$132.46M$311.14MN/A1,200

Related Companies and Tools


This page (NASDAQ:CCLD) was last updated on 8/22/2026 by MarketBeat.com Staff.
From Our Partners